Efficacy and safety of disitamab vedotin combined with toripalimab for cisplatin-refractory advanced penile cancer: A prospective single-center study (SAVE).
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Author: Fang Yuan
Institutions: Chongqing University, Chongqing Cancer Hospital
Language: English
Topic: Genital Health and Disease
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162534366